Anti-CRLF1 antibody (135-350) (STJ11102917)

SKU:
STJ11102917

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CRLF1 (135-350) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CRLF1
Gene ID: 9244
Uniprot ID: CRLF1_HUMAN
Immunogen Region: 135-350
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 135-350 of human CRLF1 (NP_004741.1).
Immunogen Sequence: PEKPVNISCWSKNMKDLTCR WTPGAHGETFLHTNYSLKYK LRWYGQDNTCEEYHTVGPHS CHIPKDLALFTPYEIWVEAT NRLGSARSDVLTLDILDVVT TDPPPDVHVSRVGGLEDQLS VRWVSPPALKDFLFQAKYQI RYRVEDSVDWKVVDDVSNQT SCRLAGLKPGTVYFVQVRCN PFGIYGSKKAGIWSEWSHPT AASTPRSERPGPGGGA
Tissue Specificity Highest levels of expression observed in spleen, thymus, lymph node, appendix, bone marrow, stomach, placenta, heart, thyroid and ovary. Strongly expressed also in fetal lung.
Function In complex with CLCF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development (Probable). May also play a regulatory role in the immune system.
Protein Name Cytokine Receptor-Like Factor 1
Cytokine-Like Factor 1
Clf-1
Zcytor5
Database Links Reactome: R-HSA-6788467
Reactome: R-HSA-9020956
Cellular Localisation Secreted
Alternative Antibody Names Anti-Cytokine Receptor-Like Factor 1 antibody
Anti-Cytokine-Like Factor 1 antibody
Anti-Clf-1 antibody
Anti-Zcytor5 antibody
Anti-CRLF1 antibody
Anti-UNQ288 antibody
Anti-PRO327 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance